Viking Therapeutics
VKTX
VKTX
116 hedge funds and large institutions have $300M invested in Viking Therapeutics in 2018 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 28 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
76% more funds holding
Funds holding: 66 → 116 (+50)
28% more call options, than puts
Call options by funds: $9.5M | Put options by funds: $7.4M
12.76% more ownership
Funds ownership: 41.07% → 53.84% (+13%)
Holders
116
Holding in Top 10
2
Calls
$9.5M
Puts
$7.4M
Top Buyers
| 1 | +$42.4M | |
| 2 | +$24.3M | |
| 3 | +$19.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.12M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$7.12M |
Top Sellers
| 1 | -$9.45M | |
| 2 | -$8.87M | |
| 3 | -$7.69M | |
| 4 |
Millennium Management
New York
|
-$6.25M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$5.68M |